Thomas D. Carey - 26 Feb 2026 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: Director
Signature: /s/ Thomas D. Carey by Tomone Tanaka, Attorney-in-Fact
Issuer symbol: LAB
Transactions as of: 26 Feb 2026
Net transactions value: +$60,000
Form type: 4
Filing time: 02 Mar 2026, 19:31:32 UTC
Previous filing: 24 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Carey Thomas D.	Director	C/O STANDARD BIOTOOLS INC., 50 MILK STREET, 10TH FLOOR, BOSTON	/s/ Thomas D. Carey by Tomone Tanaka, Attorney-in-Fact	02 Mar 2026	0001574633

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Award	$60,000	+51,282	+26%	$1.17	245,340	26 Feb 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date.
F2	The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member.